{"DataElement":{"publicId":"7484975","version":"1","preferredName":"COVID-19 Vulnerability Exposure Questionnaire Assessment Text","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._A predetermined set of questions._The quality or state of the possibility of being infected by the Sars-CoV-2 virus and developing Covid-19._Contact between an agent and a target. A state of contact or close proximity to a medicinal product, chemical, pathogen, radioisotope or other substance. NOTE: Types of exposure may be described by many qualifiers (e.g., local, systemic, acute, chronic, cumulative, environmental, population, individual, gestational, or occupational.) See also exposure (individual), intervention, extent of exposure. [After International Programme on Chemical Safety (IPCS) 2004 WHO]_a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"7484974v1.0:2018321v1.0","context":"PhenX","contextVersion":"1","DataElementConcept":{"publicId":"7484974","version":"1","preferredName":"COVID-19 Vulnerability Exposure Questionnaire","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction._A predetermined set of questions._The quality or state of the possibility of being infected by the Sars-CoV-2 virus and developing Covid-19._Contact between an agent and a target. A state of contact or close proximity to a medicinal product, chemical, pathogen, radioisotope or other substance. NOTE: Types of exposure may be described by many qualifiers (e.g., local, systemic, acute, chronic, cumulative, environmental, population, individual, gestational, or occupational.) See also exposure (individual), intervention, extent of exposure. [After International Programme on Chemical Safety (IPCS) 2004 WHO]","longName":"7482945v1.0:7492265v1.0","context":"PhenX","contextVersion":"1","ObjectClass":{"publicId":"7482945","version":"1","preferredName":"SARS Coronavirus 2 Infection","preferredDefinition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","longName":"C171133","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"COVID-19 Infection","conceptCode":"C171133","definition":"An acute infection of the respiratory tract that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Based on currently available information, SARS-CoV-2 is thought to mainly spread from person to person through respiratory droplets. Typically, there is a two- to 14-day incubation period and infected persons can present with no symptoms or mild to severe fever, dry cough, fatigue, and difficulty breathing. Dysgeusia, anosmia, and gastrointestinal and flu-like symptoms have also been reported. Older adults and persons of any age who have serious underlying medical conditions may be of higher risk for severe illness, including secondary infections, respiratory failure, and multi-organ dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2B27EBF-B5AF-38D0-E053-4EBD850A5232","latestVersionIndicator":"Yes","beginDate":"2020-10-27","endDate":null,"createdBy":"PANH","dateCreated":"2020-10-27","modifiedBy":"ONEDATA","dateModified":"2020-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7492265","version":"1","preferredName":"Vulnerability to COVID-19 Exposure Questionnaire","preferredDefinition":"The quality or state of the possibility of being infected by the Sars-CoV-2 virus and developing Covid-19.:The act of subjecting someone or something to an influencing experience.:A predetermined set of questions.","longName":"C175569:C17941:C17048","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vulnerability to COVID-19","conceptCode":"C175569","definition":"The quality or state of the possibility of being infected by the Sars-CoV-2 virus and developing Covid-19.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Exposure","conceptCode":"C17941","definition":"The act of subjecting someone or something to an influencing experience.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Questionnaire","conceptCode":"C17048","definition":"A predetermined set of questions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B35E084F-E776-6DA5-E053-4EBD850AB330","latestVersionIndicator":"Yes","beginDate":"2020-11-05","endDate":null,"createdBy":"PANH","dateCreated":"2020-11-05","modifiedBy":"ONEDATA","dateModified":"2020-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B2BFCD39-F12C-6DC8-E053-4EBD850A071E","latestVersionIndicator":"Yes","beginDate":"2020-10-28","endDate":null,"createdBy":"PANH","dateCreated":"2020-10-28","modifiedBy":"PANH","dateModified":"2020-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018321","version":"1","preferredName":"Assessment Text","preferredDefinition":"a free text field to specify information on the evaluations of the patient and the patient's disease","longName":"ASSESS_TXT","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184342","version":"1","preferredName":"Text","preferredDefinition":"Text; the words of something written.","longName":"Text","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2103-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2BC789C-301C-4477-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-26","endDate":null,"createdBy":"PWEST","dateCreated":"2002-12-26","modifiedBy":"CAMPBELB","dateModified":"2008-01-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2793652","version":"1","longName":"PhenX","context":"PhenX","ClassificationSchemeItems":[{"publicId":"7482990","version":"1","longName":"COVID-19 ","context":"PhenX"},{"publicId":"7482987","version":"1","longName":"History, Treatment and Outcomes","context":"PhenX"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Data Element COVID-19 Vulnerability Exposure Questionnaire Assessment Text does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element COVID-19 Vulnerability Exposure Questionnaire Assessment Text does not have Preferred Question Text","url":null,"context":"PhenX"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Standard","id":"B2BFCFFB-21B2-6D6E-E053-4EBD850AC001","latestVersionIndicator":"Yes","beginDate":"2020-10-28","endDate":null,"createdBy":"PANH","dateCreated":"2020-10-28","modifiedBy":"PANH","dateModified":"2020-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}